Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1998;31:621-626

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pierdomenico, S. D.
Right arrow Articles by Mezzetti, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pierdomenico, S. D.
Right arrow Articles by Mezzetti, A.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*ASCORBIC ACID
*SODIUM ASCORBATE
Medline Plus Health Information
*High Blood Pressure

(Hypertension. 1998;31:621-626.)
© 1998 American Heart Association, Inc.


Scientific Contributions

Low-Density Lipoprotein Oxidation and Vitamins E and C in Sustained and White-Coat Hypertension

Sante D. Pierdomenico; Fabrizio Costantini; Anna Bucci; Domenico De Cesare; Franco Cuccurullo; ; Andrea Mezzetti

From the Centro per lo Studio dell'Ipertensione Arteriosa, delle Dislipidemie e dell'Arteriosclerosi, Dipartimento di Medicina e Scienze dell'Invecchiamento, University G. D'Annunzio, Chieti, Italy.

Correspondence to Sante D. Pierdomenico, MD, Istituto di Patologia Medica, Policlinico S.S. Annunziata, Via dei Vestini, 66013 Chieti Scalo, Italy. E-mail pierdomenico{at}unich.it

Abstract—Low-density lipoprotein oxidation and antioxidant vitamins E and C were investigated in white-coat hypertension in comparison with sustained hypertension and normotension. We selected 21 sustained hypertensive subjects, 21 white-coat hypertensive subjects, and 21 normotensive subjects matched for gender, age, and body mass index. White-coat hypertension was defined as clinical hypertension and daytime ambulatory blood pressure <139/90 (subjects were also reclassified using 134/90 and 135/85 mm Hg as cutoff points for daytime blood pressure). Blood samples were drawn for lipid profile determination, assessment of fluorescent products of lipid peroxidation in native LDL, evaluation of susceptibility to LDL oxidation in vitro (lag phase and propagation rate), and determination of LDL vitamin E and plasma vitamins E and C contents. Compared with sustained hypertensive subjects, white-coat hypertensives had significantly lower fluorescent products of lipid peroxidation (15.4±3.4 versus 10.2±3 units of relative fluorescence/mg LDL protein, P<.05), longer lag phase (54±10 versus 88±10 minutes, P<.05), lower propagation rate (8.2±2.5 versus 5.95±2.1 nmol diene/min per mg LDL cholesterol, P<.05), higher LDL vitamin E content (8.3±1.1 versus 10.1±1.8 nmol/mg LDL cholesterol, P<.05), and plasma vitamin C content (40±13 versus 57±9 µmol/L, P<. 05). No significant difference was observed between white-coat hypertensive and normotensive subjects. The results did not change after reclassification of subjects. Our data show that white-coat hypertensive subjects do not show an enhanced propensity to LDL oxidation or reduction in antioxidant vitamins. Given the role of LDL oxidation in the development of atherosclerosis and that of vitamin E and C in protecting against it, these findings suggest that white-coat hypertension per se carries a low atherogenic risk.


Key Words: hypertension, white-coat • oxidation • LDL • vitamin E • vitamin C




This article has been cited by other articles:


Home page
HeartHome page
F Violi, L Loffredo, L Musella, and A Marcoccia
Should antioxidant status be considered in interventional trials with antioxidants?
Heart, June 1, 2004; 90(6): 598 - 602.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. Sega, G. Trocino, A. Lanzarotti, S. Carugo, G. Cesana, R. Schiavina, F. Valagussa, M. Bombelli, C. Giannattasio, A. Zanchetti, et al.
Alterations of Cardiac Structure in Patients With Isolated Office, Ambulatory, or Home Hypertension: Data From the General Population (Pressione Arteriose Monitorate E Loro Associazioni [PAMELA] Study)
Circulation, September 18, 2001; 104(12): 1385 - 1392.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
G. Block, A. R. Mangels, E. P. Norkus, B. H. Patterson, O. A. Levander, and P. R. Taylor
Ascorbic Acid Status and Subsequent Diastolic and Systolic Blood Pressure
Hypertension, February 1, 2001; 37(2): 261 - 267.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. Mezzetti, M. D. Guglielmi, S. D. Pierdomenico, F. Costantini, F. Cipollone, D. De Cesare, T. Bucciarelli, S. Ucchino, F. Chiarelli, F. Cuccurullo, et al.
Increased Systemic Oxidative Stress After Elective Endarterectomy : Relation to Vascular Healing and Remodeling
Arterioscler Thromb Vasc Biol, November 1, 1999; 19(11): 2659 - 2665.
[Abstract] [Full Text] [PDF]